Biotech Values

[LongRun8]

If true, it should be for one of the biggest premiums in your running list of buyouts of publicly traded companies. They would be fools to sell for anything less than $7B. I think they can get there organically on their own in short order if things pan out as expected over the next half year and into daxi launch.